<

 
Data updated 2025-05-02 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date19161129.2 (espacenet)  (Federated)  (European Patent Register), 20150504
Patent/reg. no. and dateDK/EP 3536380, 20210707
Publication date20190911
Priority no. and dateUS 201461990402 P, 20140508
EP pub. no. and date EP 3536380 20190911
Effective date
Applicant/ownerELI LILLY AND CO., Lilly Corporate Center
Indianapolis, IN 46285, US
Applicant ref. no.V344203DK00
InventorCHRISTE, Michael Edward, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
HARDY, Thomas Andrew, c/o Eli Lilly and Company
P.O. Box 6288
Indianapolis, Indiana 46206-6288, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 31/5585 (2006.01) , A61K 38/28 (2006.01) , A61P 3/10 (2006.01) 
TitleHurtigtvirkende insulinsammensætninger
Int. application no.
Int. publication no.
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact